Sepsis & infection

EFFECT of daily antiseptic bathing with octenidine on ICU-acquired bacteremia and ICU-acquired multidrug-resistant organisms: a multicenter, cluster-randomized, double-blind, placebo-controlled, cross-over study

Intensive Care MedPublished Cluster-randomised controlled trial

An erratum to this article was published (Intensive Care Med, Apr 2025 ↗)

Primary result · ICU-acquired primary bacteremia and ICU-acquired MDROsResult — go to the resultAdjusted hazard ratio 0.83 95% CI [0.75; 0.92]

Authors' conclusion

Antiseptic bathing with octenidine may be effective in preventing ICU-acquired primary bacteremia, particularly due to Gram-positive bacteria and common skin commensals.

Study context

Population
ICU episodes on 44 intensive care units (ICUs) in 23 hospitals throughout Germany
Participants
93,438 participants · 104,039 ICU episodes
Comparison
Daily bathing with octenidine-impregnated vs placebo washcloths
Primary endpoint
ICU-acquired primary bacteremia and ICU-acquired MDROs (algorithmically derived)
Methodological detailsmulticentre, double-blind, placebo-controlled, cross-over, ICUs compared with themselves over two 12-month periods, Data obtained digitally from hospital information systems
  • Multicentre
  • Double-blind
  • Placebo-controlled
  • Cross-over
  • ICUs compared with themselves over two 12-month periods
  • Data obtained digitally from hospital information systems

Primary result

As reported in the abstract

ICU-acquired primary bacteremia and ICU-acquired MDROs

Adjusted hazard ratio

0.83

95% CI [0.75; 0.92]

P = 0.0003

Octenidine vs Placebo
adjusted HR 0.83 (95% CI [0.75; 0.92]); P = 0.0003
ICU-acquired multidrug-resistant organisms (MDROs): no intervention effect
adjusted HR 0.98 0.98 (95% CI [0.83; 1.15])

Further findings

Pathogens in bacteremia reduction

Coagulase-negative staphylococci
53%
Enterococci
17%

Original publication

EFFECT of daily antiseptic bathing with octenidine on ICU-acquired bacteremia and ICU-acquired multidrug-resistant organisms: a multicenter, cluster-randomized, double-blind, placebo-controlled, cross-over study. Intensive Care Med. Published 17 October 2024. doi:10.1007/s00134-024-07667-2

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.